Category: Pharmaceuticals

Great Lakes Pharmaceuticals closes $3 million Series B round

July 26, 2010 by MedCity News

By Mary Vanac

Great Lakes Pharmaceuticals Inc. closed a $3.1 million Series B equity offering led by Charter Life Sciences, the Palo Alto, Calif.-based venture capital firm with an office in Cincinnati.

The company, formed by Case Western Reserve University, University Hospitals Case Medical Center and Ricerca Biosciences LLC in 2005, plans to use the investment to complete a pivotal clinical study of B-Lock, its anti-microbial catheter lock solution.

Ben Franklin backs Pennsylvania device, pharma firms

July 16, 2010 by MedCity News

By Chris Seper

Three Pennsylvania companies — a diagnostics business, an imaging company and another creating a treatment for head lice — were among nine businesses to receive a share of $1.8 million from Ben Franklin Technology Partners of Southeastern Pennsylvania.

Thermo Fisher inks supply pact with pharma giant Eli Lilly

March 26, 2010 by MassDevice staff

Thermo Fisher Scientific Inc. (NYSE:TMO) inked a five-year supply deal with Eli Lilly & Co. (NYSE:LLY) that will see it take over some of the pharma giant's clinical trial operations in Indianapolis.

Waltham, Mass.-based Thermo Fisher said its Fisher Clinical Services subsidiary will take over Lilly's in-house clinical trial materials manufacturing, packaging and labeling operations in the Circle City. That transition should be done some time this summer, and by the end of the year TMO will have taken over the clinical trial materials distribution throughout North America.

Covidien has a cure for the pain, but sales and the taxman stymie Q2 growth

April 30, 2009 by MassDevice staff

It turns out that mother's little helper can give big companies a boost too. Or at least temporarily dull the pain of a deep recession.

Covidien Ltd. rode a rising tide of sales of oxycodone hydrochloride extended-release tablets — a generic Oxycontin equivalent — to a strong second quarter.

But the boost will be short-lived, thanks to a settlement the Mansfield-based medical products giant inked last year with Stamford, Conn.-based Perdue Pharma LP.